C8 MediSensors Receives Equity Investment from GE healthymagination Fund

C8 MediSensors, Inc., a San Jose, CA-based developer of non-invasive continuous glucose monitors for diabetic patients, has received an equity investment of undisclosed amount from the GE healthymagination Fund.

The funds will enable the company to execute its business plan. C8 MediSensors plans to introduce its new non-invasive continuous glucose monitor in the European Community in 2012, pending CE Mark regulatory approval.

Led by Chairman and CEO Robert P. McNamara, Ph.D, COO Paul S. Zygielbaum, and CTO Rudy Hofmeister, Ph.D, C8 MediSensors has developed patent-protected technology that aims to improve the lives of diabetics by giving them a continuous view of their glucose levels without the inconvenience and high cost of invasive glucose monitoring.



Join the discussion